Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
The Global Fund's new funding model: what it might mean for you and your country
Eurasian Harm Reduction Network (EHRN) reports that "Recipients of the Global Fund in Eastern Europe and Central Asia (EECA) have serious reservations about the new funding model (NFM) being launched by the Global Fund in 2013. HIV and TB epidemics continue to grow across the region and people living with and / or affected by the 3 key diseases (i.e. HIV/AIDS, TB and Malaria) experience persistent health and human rights challenges."
Eurasian Harm Reduction Network (EHRN) reports that "Recipients of the Global Fund in Eastern Europe and Central Asia (EECA) have serious reservations about the new funding model (NFM) being launched by the Global Fund in 2013. HIV and TB epidemics continue to grow across the region and people living with and / or affected by the 3 key diseases (i.e. HIV/AIDS, TB and Malaria) experience persistent health and human rights challenges."
Drug users need more choices at addiction treatment facilities
"The brothers Arash and Kamiar Alaei—internationally celebrated doctors who advanced treatment for drug users in Iran but were imprisoned, to the vociferous protest of the international medical community (BMJ 2009;338:b109, doi:10.1136/bmj.b109)—set out their experiences and hopes for harm reduction"
"The brothers Arash and Kamiar Alaei—internationally celebrated doctors who advanced treatment for drug users in Iran but were imprisoned, to the vociferous protest of the international medical community (BMJ 2009;338:b109, doi:10.1136/bmj.b109)—set out their experiences and hopes for harm reduction"
Promoting abstinence for drug users is about saving money not science
Jason Luty UK consultant psychiatrist, writes a personal view in the BMJ that "Despite overwhelming evidence that substitution therapy reduces harm, the UK government now advocates abstinence." He also states that: It has been proved beyond all reasonable doubt that opioid substitution reduces drug use and crime and improves physical and mental health and social functioning”. His comments about collecting of unnecessary data are also welcome: “We should abolish this time wasting control freakery and needless bureaucracy. The only function of this sort of nonsense is to keep policy writers and bureaucrats in employment at taxpayers’ expense.”
Jason Luty UK consultant psychiatrist, writes a personal view in the BMJ that "Despite overwhelming evidence that substitution therapy reduces harm, the UK government now advocates abstinence." He also states that: It has been proved beyond all reasonable doubt that opioid substitution reduces drug use and crime and improves physical and mental health and social functioning”. His comments about collecting of unnecessary data are also welcome: “We should abolish this time wasting control freakery and needless bureaucracy. The only function of this sort of nonsense is to keep policy writers and bureaucrats in employment at taxpayers’ expense.”
Rapid Response: Promoting abstinence for drug users is about saving money not science
A rapid response to Dr. Luty’s personal view from Dr Andrew Byrne, an addiction treatment physician from Australia."
A rapid response to Dr. Luty’s personal view from Dr Andrew Byrne, an addiction treatment physician from Australia."
UNODC report: The challenge of new psychoactive substances
In response to a request from last year's session of the Commission on Narcotic Drugs, UNODC has prepared a technical report on the challenges presented by new psychoactive substances (NPS). These substances, sometimes referred to as 'legal highs', are multiplying in numbers and becoming more widespread geographically, causing great concern as officials struggle to contain them.
In response to a request from last year's session of the Commission on Narcotic Drugs, UNODC has prepared a technical report on the challenges presented by new psychoactive substances (NPS). These substances, sometimes referred to as 'legal highs', are multiplying in numbers and becoming more widespread geographically, causing great concern as officials struggle to contain them.
Eyes wide open: a film about overdose prevention and ntervention
"The film recalls the experiences of people affected by an accidental opioid overdose and the emergency medicine naloxone. Based on true stories from 2 Canadian cities, this short documentary offers a window into the moment between life and death—and highlights the need for expanding overdose prevention."
"The film recalls the experiences of people affected by an accidental opioid overdose and the emergency medicine naloxone. Based on true stories from 2 Canadian cities, this short documentary offers a window into the moment between life and death—and highlights the need for expanding overdose prevention."
International Network of People who Use Drugs statement to the Plenary of the Commission on Narcotic Drugs
This statement is given on behalf of the International Network of People who Use Drugs and is given in endorsement of the Support Don't Punish campaign.
This statement is given on behalf of the International Network of People who Use Drugs and is given in endorsement of the Support Don't Punish campaign.
Norway May Decriminalize Heroin Inhalation, Allow Smoking In Order To Cut Down Overdose Rate
The Norwegian government is considering decriminalizing heroin inhalation as a means to reduce overdoses.
The Norwegian government is considering decriminalizing heroin inhalation as a means to reduce overdoses.
The challenge of new psychoactive substances
This report is the first global situation assessment on new psychoactive substances put forward under the Global SMART Programme and pursuant to Commission on Narcotic Drugs Resolution 55/1 on “Promoting international cooperation in responding to the challenges posed by new psychoactive substances”
This report is the first global situation assessment on new psychoactive substances put forward under the Global SMART Programme and pursuant to Commission on Narcotic Drugs Resolution 55/1 on “Promoting international cooperation in responding to the challenges posed by new psychoactive substances”
Open Letter to the Media and Policy Makers Regarding Alarmist and Inaccurate Reporting on Prescription Opiate Use by Pregnant Women
An open letter spearheaded by IDHDP member, Robert Newman and National Advocates for Pregnant Women, and joined by leading clinical and research experts calls for policies addressing prenatal exposure to opiates based on scientific evidence, and ending the perpetuation of misinformation and prejudice against pregnant women who use opiates.
An open letter spearheaded by IDHDP member, Robert Newman and National Advocates for Pregnant Women, and joined by leading clinical and research experts calls for policies addressing prenatal exposure to opiates based on scientific evidence, and ending the perpetuation of misinformation and prejudice against pregnant women who use opiates.
